Molecular pathology for classification of tumors and for efficacy prediction of specific therapies is really a promptly developing subject.In spite of considerable endeavours, the cure for breast most cancers awaits an improved understanding of the pathophysiology of metastasis. We stand now at the border of a new period of technological know-how,